Liposome-Based Drug Delivery Systems

;Liposomes in Drug Delivery: Status and Advances;

Preparation of Drug Liposomes by Thin-Film Hydration and Homogenization;

Preparation of Drug Liposomes by Reverse-Phase Evaporation;

Preparation of Drug Liposomes by EDTA Gradient Methods;

Preparation and Characterization of Drug Liposomes by pH-Gradient Method;

Preparation and Characterization of Drug Liposomes by Ammonium Sulfate Gradient;

Preparation and Characterization of Drug Liposomes by Nigericin Ionophore;

Lipid-Coated Cisplatin Nanoparticles for Insoluble Drug Loading;

Purification Method of Drug-Loaded Liposome;

Quality Evaluation of Drug-Loaded Liposomes;

Coupling Methods of Antibodies and Ligands for Liposomes;

Preparation of Cell Penetrating Peptides-Mediated Targeting Drug Liposomes;

Preparation and Evaluation of Folate Receptor Mediated Targeting Liposomes;

Preparation and Evaluation of Rivastigmine Liposomes for Intranasal Delivery;

Preparation and Evaluation of Integrin Receptor-Mediated Targeting Drug Liposomes;

Preparation and Evaluation of Biomineral-Binding Antibiotic Liposomes;

Preparation of Anthracyclines Liposomes for Tumor-Targeting Drug Delivery;

Preparation and Characterization of pH Sensitive Drug Liposomes;

Preparation and Characterization of DNA Liposomes Vaccine; HER2-Specific PEGylated Immunoliposomes Prepared by Lyophilization/Rehydration Method;

Fabrication and Evaluation of Dual Peptides-Modified Liposomes Coencapsulating siRNA and Docetaxel;

Dual-Modified siRNA-Loaded Liposomes for Prostate Cancer Therapy;

Dequalinium-Mediated Mitochondria-Targeting Drug Liposomes for the Treatment of Drug-Resistant Lung Cancer;

Preparation of Multifunctional Paclitaxel Liposomes forTreatment of Brain Glioma;

Preparation of Functional Vincristine Liposomes for Treatment of Invasive Breast Cancer;

Application of Labeled Liposomes in Imaging and Biodistribution Observation;

Application of Drug Liposomes in the Hormone Therapy;

Application of Drug Liposomes in Gene Transfection

Prof. Dr. Wan-Liang Lu a principal investigator in State Key Laboratory of Natural and Biomimetic Drugs, Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Systems, and School of Pharmaceutical Sciences, Peking University, Beijing, China

Prof. Dr. Xian-Rong Qi a principal investigator in Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Systems, Department of Pharmaceutics, and School of Pharmaceutical Sciences, Peking University, Beijing, China